Tekla Capital Management’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Tekla Capital Management’s Portfolio IPCI Stock Details IPCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-35,405	Closed	-$1.04M	–	174
2015 Q2	$1.04M	Sell	35,405 -103,995	-75%	-$3.14M	0.04%	106
2015 Q1	$3.89M	Sell	139,400 -1,000	-0.7%	-$24.3K	0.15%	90
2014 Q4	$3.17M	Hold	140,400	–	–	0.15%	80
2014 Q3	$4.23M	Hold	140,400	–	–	0.2%	89
2014 Q2	$5.35M	Hold	140,400	–	–	0.49%	46
2014 Q1	$6.18M	Hold	140,400	–	–	0.62%	41
2013 Q4	$5.2M	Sell	140,400 -33,100	-19%	-$888K	0.55%	37
2013 Q3	$3.4M	Hold	173,500	–	–	0.38%	50
2013 Q2	$2.81M	Buy	+173,500	New	+$3.2M	0.38%	48

Other funds holding IPCI

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

FFA

First Foundation Advisors Irvine, California $2.78B AUM 23.76% 1-Year Est. Return

FMBTD

First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return

NCCM

Nine Chapters Capital Management Short Hills, New Jersey $45.4M AUM 14.43% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return

AIG

American International Group New York $2.93M AUM 12.08% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Tekla Capital Management's IPCI Position: Q3 2015 in Review

Tekla Capital Management sold out of Intellipharmaceuticals International Inc. (IPCI) in Q3 2015, closing a stake of 35,405 shares — an estimated $1.04M sold.

Tekla Capital Management first reported a position in IPCI in Q2 2013 and held it in 9 quarters. The position peaked at $6.18M in Q1 2014. 18 funds tracked by Wall St. Rank hold IPCI as of Q3 2015.

Tekla Capital Management reported no remaining Intellipharmaceuticals International Inc. position as of Q3 2015 after selling out during the quarter.
Tekla Capital Management sold 35,405 Intellipharmaceuticals International Inc. shares in Q3 2015, an estimated $1.04M.
Tekla Capital Management first reported a position in Intellipharmaceuticals International Inc. in Q2 2013 and held it in 9 quarters.
Tekla Capital Management's Intellipharmaceuticals International Inc. position peaked at $6.18M in Q1 2014.
18 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q3 2015.

Based on Tekla Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.